AUD 0.05
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | - AUD | 0.0% |
2023 | - AUD | 0.0% |
2022 | - AUD | 0.0% |
2021 | - AUD | 0.0% |
2020 | - AUD | -100.0% |
2019 | 663.4 Thousand AUD | 10158.31% |
2018 | 6467.00 AUD | -99.77% |
2017 | 2.85 Million AUD | 16.56% |
2016 | 2.44 Million AUD | 3888.63% |
2015 | 61.38 Thousand AUD | -31.8% |
2014 | 90 Thousand AUD | 0.0% |
2013 | 90 Thousand AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 FY | - AUD | 0.0% |
2024 Q4 | -272.74 Thousand AUD | 0.0% |
2024 Q2 | 272.74 Thousand AUD | 0.0% |
2023 FY | - AUD | 0.0% |
2023 Q4 | -395.92 Thousand AUD | 0.0% |
2023 Q2 | 395.92 Thousand AUD | 0.0% |
2022 Q2 | 318.77 Thousand AUD | 0.0% |
2022 FY | - AUD | 0.0% |
2022 Q4 | -318.77 Thousand AUD | 0.0% |
2021 Q4 | -685.61 Thousand AUD | 0.0% |
2021 Q2 | 685.61 Thousand AUD | 0.0% |
2021 FY | - AUD | 0.0% |
2020 Q2 | 417.35 Thousand AUD | 0.0% |
2020 FY | - AUD | -100.0% |
2020 Q4 | -417.35 Thousand AUD | 0.0% |
2019 FY | 663.4 Thousand AUD | 10158.31% |
2019 Q4 | 640.07 Thousand AUD | 0.0% |
2019 Q2 | 486.62 Thousand AUD | 0.0% |
2018 FY | 6467.00 AUD | -99.77% |
2018 Q4 | -846.23 Thousand AUD | 0.0% |
2018 Q2 | 852.69 Thousand AUD | 0.0% |
2017 Q2 | 1.93 Million AUD | 0.0% |
2017 FY | 2.85 Million AUD | 16.56% |
2017 Q4 | 917.63 Thousand AUD | 0.0% |
2016 Q2 | 165.24 Thousand AUD | 0.0% |
2016 FY | 2.44 Million AUD | 3888.63% |
2016 Q4 | 2.28 Million AUD | 0.0% |
2015 Q2 | - AUD | 0.0% |
2015 FY | 61.38 Thousand AUD | -31.8% |
2015 Q4 | 61.38 Thousand AUD | 0.0% |
2014 Q3 | - AUD | -100.0% |
2014 Q2 | 45 Thousand AUD | 0.0% |
2014 FY | 90 Thousand AUD | 0.0% |
2014 Q4 | 45 Thousand AUD | 0.0% |
2013 FY | 90 Thousand AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
EZZ Life Science Holdings Limited | 66.44 Million AUD | 100.0% |
Zelira Therapeutics Limited | 94.95 Thousand AUD | 100.0% |
Biome Australia Limited | 13 Million AUD | 100.0% |
Patrys Limited | 1.39 Million AUD | 100.0% |
Orthocell Limited | 5.31 Million AUD | 100.0% |
Imugene Limited | - AUD | NaN% |
Noxopharm Limited | 2.4 Million AUD | 100.0% |
PYC Therapeutics Limited | 22.05 Million AUD | 100.0% |
Chimeric Therapeutics Limited | 7.45 Million AUD | 100.0% |
Prescient Therapeutics Limited | 3.71 Million AUD | 100.0% |
Proteomics International Laboratories Limited | 892.14 Thousand AUD | 100.0% |
Cynata Therapeutics Limited | 2.31 Million AUD | 100.0% |
CSL Limited | 22.41 Billion AUD | 100.0% |
Arovella Therapeutics Limited | 17 Thousand AUD | 100.0% |
Bio-Gene Technology Limited | 18.32 Thousand AUD | 100.0% |
Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 100.0% |
Starpharma Holdings Limited | 8.28 Million AUD | 100.0% |
Nanollose Limited | 12.5 Thousand AUD | 100.0% |
Memphasys Limited | 60 Thousand AUD | 100.0% |
Invex Therapeutics Ltd | 1.21 Million AUD | 100.0% |
NeuroScientific Biopharmaceuticals Limited | - AUD | NaN% |
Amplia Therapeutics Limited | 4.45 Million AUD | 100.0% |
Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 100.0% |
Island Pharmaceuticals Limited | 1.25 Million AUD | 100.0% |
Race Oncology Limited | 4 Million AUD | 100.0% |
Nyrada Inc. | - AUD | NaN% |
Telix Pharmaceuticals Limited | 496.65 Million AUD | 100.0% |
Dimerix Limited | 583.47 Thousand AUD | 100.0% |
PharmAust Limited | - AUD | NaN% |
Immutep Limited | 3.5 Million AUD | 100.0% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 100.0% |
Alterity Therapeutics Limited | 4.01 Million AUD | 100.0% |
BTC Health Limited | 16.36 Thousand AUD | 100.0% |
Acrux Limited | 5.09 Million AUD | 100.0% |
Neuren Pharmaceuticals Limited | 231.92 Million AUD | 100.0% |
Biotron Limited | - AUD | NaN% |
Tissue Repair Ltd | 152.24 Thousand AUD | 100.0% |
AdAlta Limited | 1.73 Million AUD | 100.0% |
Radiopharm Theranostics Limited | 299.22 Thousand AUD | 100.0% |
Hexima Limited | - AUD | NaN% |
AnteoTech Limited | 460.39 Thousand AUD | 100.0% |
Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | 100.0% |
Recce Pharmaceuticals Ltd | - AUD | NaN% |
Avecho Biotechnology Limited | 473.55 Thousand AUD | 100.0% |
Actinogen Medical Limited | 9.93 Million AUD | 100.0% |
Immuron Limited | 4.9 Million AUD | 100.0% |
Argenica Therapeutics Limited | 2.59 Million AUD | 100.0% |